/
Sign inStart free
Menu

Earnings call · Apr–Jun 2026

Divi's Laboratories Ltd.

Transcript filed on BSE on 6 Aug 2026 · 3 people from the company · 12 analysts asked questions

From the company

  • Kiran S. DiviWhole-Time Director and
  • Nilima Prasad DiviWhole-Time Director
  • Satish ChoudhuryCompany Secretary

Questions came from

Topics in this call

Capex & capacity 23Costs 18Prices 14Demand 13Margins 12Outlook 5Orders & deals 5

Opening remarks

Kiran S. DiviWhole-Time Director and

Good afternoon everyone, and welcome to the Divi’s Laboratories earnings call for the first quarter of the financial year 2026-27. Thank you for joining us today. I will begin with an update on the business and the key operational developments during the quarter. Our focus continues to be on execution, manufacturing reliability, disciplined capital deployment and strengthening the capabilities required to support long-term customer programmes.

Beginning with our Generic business, volumes remained stable during the quarter, while pricing continues to reflect competitive market conditions across products and geographies. Overall, the

Read the whole call: 198 paragraphs, 12 analysts' questions with every answer.

Premium opens every call in full: the notes, the marked passages, search & topic jumps, for every company that files a transcript.

The transcript as the company filed it on BSE. Our own rules split it into speakers & sections; an unusual layout can trip them, so check the original PDF for anything important. Not a recommendation.

HV Investing Premium

Get the gist of each earnings call

See Premium plans

₹499 a month or ₹4,999 a year. Cancel anytime.

or start free, no card needed

Already a member?Sign in